![David Zacut](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Zacut
Fondateur chez
BRAINSWAY LTD.
Fortune : 21 M $ au 31/10/2026
Profil
Dr. David Zacut, MD, is a Vice Chairman at Brainsway Ltd. He is on the Board of Directors at Brainsway Ltd., Brain Research & Development Services Ltd., Brainsway USA, Inc., Brainsway, Inc., Hadasit Medical Research Services & Development Ltd., Meromei Elran David 2003 Ltd., Psychacolor Ltd. and Zakhut Eliyahu Ltd. He received his doctorate degree from The Hebrew University of Jerusalem.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BRAINSWAY LTD 4,43 % | 23/03/2026 | 1 785 218 ( 4,43 % ) | 21 M $ | 31/10/2026 |
Postes actifs de David Zacut
| Sociétés | Poste | Début |
|---|---|---|
| BRAINSWAY LTD. | Fondateur | 01/01/2003 |
Brain Research & Development Services Ltd. | Directeur/Membre du Conseil | 01/05/2001 |
Meromei Elran David 2003 Ltd. | Directeur/Membre du Conseil | - |
Zakhut Eliyahu Ltd. | Directeur/Membre du Conseil | - |
Psychacolor Ltd. | Directeur/Membre du Conseil | - |
Brainsway USA, Inc. | Directeur/Membre du Conseil | - |
Brainsway, Inc.
 Brainsway, Inc. Electronic Equipment/InstrumentsElectronic Technology Part of Brainsway Ltd., Brainsway, Inc. is an Israeli medical technology company specializing in the development and manufacturing of patented deep transcranial magnetic stimulation (Deep TMS™) devices. The company is based in Jerusalem, Israel. The company’s Deep TMS technology uses a unique H-coil design to non-invasively stimulate deeper and broader brain regions than traditional TMS, targeting neural circuits involved in various psychiatric and neurological disorders. Deep TMS treatments are FDA-cleared for major depressive disorder, obsessive-compulsive disorder, and short-term smoking cessation, with additional approvals for indications such as anxiety, bipolar disorder, post-traumatic stress disorder, schizophrenia (negative symptoms), Alzheimer’s disease, autism spectrum disorder, chronic pain, multiple sclerosis, Parkinson’s disease, and post-stroke rehabilitation. Some indications are investigational or not commercially available in all markets. The company supports patients, healthcare providers, and researchers with educational resources, clinical research collaborations, practice support, and tools to locate certified treatment centers worldwide. | Directeur/Membre du Conseil | - |
Hadasit Medical Research Services & Development Ltd.
 Hadasit Medical Research Services & Development Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Directeur/Membre du Conseil | - |
Formation de David Zacut
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
63
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
The Hebrew University of Jerusalem
 The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hadasit Medical Research Services & Development Ltd.
Hadasit Medical Research Services & Development Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
Brainsway Ltd.
 Brainsway Ltd. Medical SpecialtiesHealth Technology Develops, manufactures and markets deep transcranial magnetic stimluation systems, novel, noninvasive medical devices | Health Technology |
Brain Research & Development Services Ltd. | Commercial Services |
Meromei Elran David 2003 Ltd. | |
Zakhut Eliyahu Ltd. | |
Psychacolor Ltd. | |
Brainsway USA, Inc. | |
Brainsway, Inc.
Brainsway, Inc. Electronic Equipment/InstrumentsElectronic Technology Part of Brainsway Ltd., Brainsway, Inc. is an Israeli medical technology company specializing in the development and manufacturing of patented deep transcranial magnetic stimulation (Deep TMS™) devices. The company is based in Jerusalem, Israel. The company’s Deep TMS technology uses a unique H-coil design to non-invasively stimulate deeper and broader brain regions than traditional TMS, targeting neural circuits involved in various psychiatric and neurological disorders. Deep TMS treatments are FDA-cleared for major depressive disorder, obsessive-compulsive disorder, and short-term smoking cessation, with additional approvals for indications such as anxiety, bipolar disorder, post-traumatic stress disorder, schizophrenia (negative symptoms), Alzheimer’s disease, autism spectrum disorder, chronic pain, multiple sclerosis, Parkinson’s disease, and post-stroke rehabilitation. Some indications are investigational or not commercially available in all markets. The company supports patients, healthcare providers, and researchers with educational resources, clinical research collaborations, practice support, and tools to locate certified treatment centers worldwide. | Electronic Technology |
